Dear Senator/Representative:
"The NCCC report includes detailed recommendations to address the ongoing diabetes epidemic. We want to call your attention to some of the recommendations that are particularly timely as Congress continues to consider ways to lower the cost of prescription medications, appropriations for FY 2022, and changes in healthcare resulting from the COVID-19 pandemic. The report recommends ways to improve access to affordable insulin including allowing the government to negotiate lower drug prices and limiting cost-sharing to a co-pay of no more than $35 a month. The report also recommends investing more funding into diabetes research and prevention programs including the Special Diabetes Program, the Diabetes Prevention Program at the CDC, and research funding at the National Institutes of Health (NIH). Finally, the report includes recommendations to improve virtual care modalities including removing geographic and ongoing site restrictions and maintain coverage of audio-only visits which are currently allowed under the COVID-19 Public Health Emergency. The Society supports all of these recommendations."
Read the Full Letter